Key takeaways

  • No cervical cancer deaths recorded among English women in their early 20s, 2020-2024
  • UK's HPV vaccine, introduced in 2008, credited with preventing around 200 deaths
  • Researchers say high vaccination uptake is key to sustaining this progress
  • Portugal has its own HPV programme, recently extended to more age groups

New research examining UK mortality data between 2020 and 2024 has found no recorded cervical cancer deaths among women in their early twenties in England, a milestone scientists are linking directly to the country’s HPV vaccination programme. Researchers described the findings as the clearest evidence yet that the vaccine is saving lives.

What the UK Data Shows

The HPV vaccine was introduced in the UK in 2008 after research established a strong link between certain strains of the human papillomavirus and cervical cancer. Since then, the vaccine has been rolled out to teenagers, primarily girls, though many countries including the UK have since extended eligibility to boys as well.

According to the new analysis, the risk of dying from cervical cancer before age 30 has effectively dropped to zero among vaccinated cohorts. Researchers estimate that around 200 deaths have already been prevented in England alone, with the full impact expected to grow as more vaccinated generations move into their thirties and forties, the ages when cervical cancer risk typically rises.

Why the Findings Matter Beyond Britain’s Borders

Scientists involved in the research were clear that the gains depend on maintaining high vaccination rates. Any decline in uptake, they warned, could slow or reverse the progress made over the past decade and a half.

For readers in Portugal, the story carries a domestic echo. Portugal has run its own HPV vaccination programme for years and recently extended eligibility to additional age groups, a move health authorities have framed as part of a broader push to cut cancer rates nationally. Portugal’s cervical cancer survival rate and overall cancer survival figures have also been cited in recent local reporting, with the national cancer survival rate reaching 66 percent.

What Foreign Residents Should Know About Local Vaccination Access

Foreign residents raising children in Portugal, or bringing teenagers into the Portuguese health system via the SNS, can generally access HPV vaccination through the national immunisation schedule, which is offered free of charge at local health centres. Those unsure of eligibility, particularly for older teenagers or young adults who may have missed the standard vaccination age, should check directly with their local health centre (centro de saúde), since eligibility windows have been expanding in Portugal as elsewhere.

The UK findings offer a preview of what health authorities hope to see reflected in Portuguese data in the coming years, as the first fully vaccinated generations here also reach adulthood.